MedTrace Logo

The Treatment of Bronchopulmonary Dysplasia by Intratracheal Instillation of Mesenchymal Stem Cells

NCT03683953 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-09-25

No results posted yet for this study

Summary

To study the effect and saftey of intratracheal instillation of mesenchymal stem cells for treatment BPD

Conditions

  • Safety Issues
  • Effect of Drugs

Interventions

OTHER

mesenchymal stem cells therapy

mesenchymal stem cells treatement of BPD for safety and effect evaluation0.9% sodium chloride incontrol group

DRUG

0.9% sodium chloride

0.9% sodium chloride in control group

Sponsors & Collaborators

  • Guangdong Women and Children Hospital

    lead OTHER

Principal Investigators

  • Jie Yang, PHD · Guangzhou, Guangdong,China，511442

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
28 Weeks
Max Age
37 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-29
Primary Completion
2019-08-01
Completion
2020-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03683953 on ClinicalTrials.gov